Financhill
Back

Ligand Pharmaceuticals, Inc. Stock Price Chart

Bitcoin was First. NatGold is the Masterpiece.

Reserve Your Tokens Now
Sell
39

LGND
Ligand Pharmaceuticals, Inc.

Last Price:
$191.89
Seasonality Move:
4.71%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mega-Cap Trade Is Crowded: These 5 Tech Stocks Could Soar

Get your free report now.
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing slight selling pressure.

Ligand Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 196.97 Sell
20-day SMA: 196.85 Sell
50-day SMA: 196.16 Sell
200-day SMA: 156.32 Buy
8-day EMA: 76.39 Buy
20-day EMA: 35.1 Buy
50-day EMA: 14.88 Buy
200-day EMA: 3.83 Buy

Ligand Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 27.33 Buy
Relative Strength Index (14 RSI): 45.89 Sell
Chaikin Money Flow: -45916 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (191.69 - 201.33) Sell
Bollinger Bands (100): (176.87 - 201.25) Buy

Ligand Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Ligand Pharmaceuticals, Inc. Stock

Is Ligand Pharmaceuticals, Inc. Stock a Buy?

LGND Technical Analysis vs Fundamental Analysis

Sell
39
Ligand Pharmaceuticals, Inc. (LGND) is a Sell

Is Ligand Pharmaceuticals, Inc. a Buy or a Sell?

Ligand Pharmaceuticals, Inc. Stock Info

Market Cap:
3.8B
Price in USD:
192.10
Share Volume:
184.9K

Ligand Pharmaceuticals, Inc. 52-Week Range

52-Week High:
212.49
52-Week Low:
93.58
Sell
39
Ligand Pharmaceuticals, Inc. (LGND) is a Sell

Ligand Pharmaceuticals, Inc. Share Price Forecast

Is Ligand Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Ligand Pharmaceuticals, Inc.

Is Ligand Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and an increase next year of $1.18 per share.

Technical Analysis of Ligand Pharmaceuticals, Inc.

Should I short Ligand Pharmaceuticals, Inc. stock?

* Ligand Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.